Literature DB >> 25880517

Cardiac fibroblast physiology and pathology.

David Dostal1, Shannon Glaser2, Troy A Baudino3.   

Abstract

Cardiac function is mediated by interactions between the cellular constituents of the heart, as well as the extracellular matrix. The major cell types of the heart include cardiac fibroblasts, myocytes, endothelial cells, and vascular smooth muscle cells. In addition, there are also resident stem cells and transient cell types, such as immune cells. Interactions in the heart include chemical, mechanical, and electrical signals, which vary depending on the developmental stage, disease state, and specific cell type. Understanding how these different signals interact at the molecular, cellular, and organ levels is important for better understanding cardiac function under a variety of physiological and pathological conditions. Cardiac fibroblasts play key roles in maintaining normal cardiac form and function, as well as in the cardiac remodeling process during pathological conditions, such as myocardial infarction and hypertension. Regardless of normal or pathological status of the heart, fibroblasts have multiple functions, such as synthesis and deposition of extracellular matrix and cell-cell communication with other cardiac cells, including myocytes and endothelial cells. Interactions with other cell types can affect multiple cell signaling pathways (e.g., ERK, JNK, and p38), the expression and secretion of numerous growth factors and cytokines, microRNA exchange, gene and protein expression, and angiogenesis. In this review, we provide insight into the cardiac fibroblast under normal and pathological conditions to illustrate their importance in maintaining proper cardiac function.
© 2015 American Physiological Society.

Entities:  

Mesh:

Year:  2015        PMID: 25880517     DOI: 10.1002/cphy.c140053

Source DB:  PubMed          Journal:  Compr Physiol        ISSN: 2040-4603            Impact factor:   9.090


  15 in total

1.  Gq-activated fibroblasts induce cardiomyocyte action potential prolongation and automaticity in a three-dimensional microtissue environment.

Authors:  C M Kofron; T Y Kim; M E King; A Xie; F Feng; E Park; Z Qu; B-R Choi; U Mende
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-07-14       Impact factor: 4.733

Review 2.  Role of the immune system in cardiac tissue damage and repair following myocardial infarction.

Authors:  Arman Saparov; Vyacheslav Ogay; Talgat Nurgozhin; William C W Chen; Nurlan Mansurov; Assel Issabekova; Jamilya Zhakupova
Journal:  Inflamm Res       Date:  2017-06-09       Impact factor: 4.575

3.  Stem cell therapy of myocardial infarction: a promising opportunity in bioengineering.

Authors:  Bin Jiang; Li Yan; James G Shamul; Maxwell Hakun; Xiaoming He
Journal:  Adv Ther (Weinh)       Date:  2020-02-03

4.  The Functional Pluralism of Fibroblasts in the Infarcted Myocardium.

Authors:  Nikolaos G Frangogiannis
Journal:  Circ Res       Date:  2016-10-28       Impact factor: 17.367

Review 5.  Extracellular matrix-mediated cellular communication in the heart.

Authors:  Iñigo Valiente-Alandi; Allison E Schafer; Burns C Blaxall
Journal:  J Mol Cell Cardiol       Date:  2016-01-14       Impact factor: 5.000

6.  Enhanced expression and phosphorylation of Sirt7 activates smad2 and ERK signaling and promotes the cardiac fibrosis differentiation upon angiotensin-II stimulation.

Authors:  Haichen Wang; Shengwu Liu; Shengqiang Liu; Wei Wei; Xiaolong Zhou; Fang Lin; Juanjuan Wang; Jinye Chen; Guodong Zhang; Yongbing Pang
Journal:  PLoS One       Date:  2017-06-05       Impact factor: 3.240

7.  Andrographolide Protects against Aortic Banding-Induced Experimental Cardiac Hypertrophy by Inhibiting MAPKs Signaling.

Authors:  Qing Q Wu; Jian Ni; Ning Zhang; Hai H Liao; Qi Z Tang; Wei Deng
Journal:  Front Pharmacol       Date:  2017-11-14       Impact factor: 5.810

8.  Human-iPSC-Derived Cardiac Stromal Cells Enhance Maturation in 3D Cardiac Microtissues and Reveal Non-cardiomyocyte Contributions to Heart Disease.

Authors:  Elisa Giacomelli; Viviana Meraviglia; Giulia Campostrini; Amy Cochrane; Xu Cao; Ruben W J van Helden; Ana Krotenberg Garcia; Maria Mircea; Sarantos Kostidis; Richard P Davis; Berend J van Meer; Carolina R Jost; Abraham J Koster; Hailiang Mei; David G Míguez; Aat A Mulder; Mario Ledesma-Terrón; Giulio Pompilio; Luca Sala; Daniela C F Salvatori; Roderick C Slieker; Elena Sommariva; Antoine A F de Vries; Martin Giera; Stefan Semrau; Leon G J Tertoolen; Valeria V Orlova; Milena Bellin; Christine L Mummery
Journal:  Cell Stem Cell       Date:  2020-05-26       Impact factor: 24.633

Review 9.  Cardiac Fibroblast p38 MAPK: A Critical Regulator of Myocardial Remodeling.

Authors:  Neil A Turner; Nicola M Blythe
Journal:  J Cardiovasc Dev Dis       Date:  2019-08-07

Review 10.  Systems Medicine as an Emerging Tool for Cardiovascular Genetics.

Authors:  Tina Haase; Daniela Börnigen; Christian Müller; Tanja Zeller
Journal:  Front Cardiovasc Med       Date:  2016-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.